Wednesday, June 22, 2016
- 12:00pm-1:30pm
-
Juvenile chorea: Diagnostic criterias, prediction of movement disorders
Choreas (non-Huntington's disease) · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Lessons-experienced in the creation of a global public-private consortium with the goal of advancing treatments that hold most potential for delayed disease progression in Parkinson’s disease – Critical path for Parkinson’s (CPP)
Parkinson's disease: Neuroimaging and neurophysiology · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Levodopa impairs learning in healthy young adults: Implications for Parkinson’s disease
Cognitive disorders · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Levodopa induced dyskinesia and nicotinergic α4β2 acetylcholin receptor density: A multi-tracer imaging study
- 12:00pm-1:30pm
-
Long term prognosis of functional motor disorders, a case-control follow-up study
Phenomenology and clinical assessment of movement disorders · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Long-term impact of lead poisoning on neurologic function in children and adolescents
Ataxia · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Longterm outcome of cognition following subthalamic deep brain stimulation in Parkinson´s disease
Parkinson's disease: Cognition · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Loss of extra-striatal phosphodiesterase 10A expression in early premanifest Huntington’s disease gene carriers
- 12:00pm-1:30pm
-
Magnetic resonance imaging and pyramidal impairment in Huntington disease
Huntington's disease · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Magnetic resonance imaging in spinocerebellar ataxias: A systematic review
Ataxia · Exhibit Hall located in Hall B, Level 2
- «Previous Page
- 1
- …
- 28
- 29
- 30
- 31
- 32
- …
- 54
- Next Page»